CPD Courses

Time to challenge 1L mCRPC – a combination treatment to expand options for patients 

Training Course AstraZeneca

About the CPD course

The meeting aims to highlight the key clinical trial data of LYNPARZA (olaparib) combination therapy and discusses the management of AEs and monitoring of patients receiving the combination therapy.

CPD Provider

AstraZeneca

Send an enquiry

By submitting this form, you consent to CPD sending you email regarding your application.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

AstraZeneca

AstraZeneca

At AstraZeneca, we are transforming the future of healthcare by unlocking the power of what science can do – for people, society and the planet. The UK plays a key role within the global AstraZeneca network. It is home to colleagues from across the full life sciences value chain. Everything we do is driven by science to transform healthcare and patient outcomes, while playing a purpose-led role in wider society.

Want to learn more?

More CPD courses by AstraZeneca

Healthcare & Medical

Challenging the Status Quo in CKD Management

AstraZeneca

A presentation developed for healthcare professionals in GB or Northern Ireland; sharing information...
Seminar
Healthcare & Medical

Expanding treatment options in 1L mCRPC

AstraZeneca

LYNPARZA ‘meeting in a box’ (MIAB) slide deck. The presentation aims to highlight the unmet need and...
Training Course
Healthcare & Medical

Time to challenge treatment options in 1L mCRPC; L...

AstraZeneca

The presentation aims to highlight the evolving landscape of 1L mCRPC therapy; as well as licensing...
Training Course
Healthcare & Medical

The Fundamentals of Immunology in Severe Asthma

AstraZeneca

This is 3 part series of medical education that can be delivered by our medical science liaison team...
Training Course

Get industry-related content straight to your inbox

By signing up to our site you are agreeing to our privacy policy